COMMUNIQUÉS West-GlobeNewswire

Corvus Pharmaceuticals Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Business Update
07/03/2019
BURLINGAME, Calif., March 07, 2019 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (Nasdaq: CRVS), a clinical-stage biopharmaceutical company focused on the development and commercialization of precisely targeted [...]
Calithera Biosciences Reports Fourth Quarter 2018 Financial Results and Recent Highlights
07/03/2019
-Calithera to Provide Corporate Update via Conference Call and Webcast at 1:30 p.m. PT on March 7, 2019 SOUTH SAN FRANCISCO, Calif., March 07, 2019 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq: CALA), a [...]
Autolus Therapeutics to Host R&D Day on March 26, 2019
07/03/2019
Company to highlight next-generation, novel programmed T cell therapies in development for hematological and solid tumor indications Program and webcast to begin at 8:00 am ET LONDON, March 07, 2019 (GLOBE NEWSWIRE) -- [...]
HTG Molecular Diagnostics Reports Full Year 2018 Results
07/03/2019
Revenue increased 46% in 2018 compared to the prior year reflecting continued success growing the company’s profiling business with Pharma company customers TUCSON, Ariz., March 07, 2019 (GLOBE NEWSWIRE) -- HTG [...]
Integra LifeSciences to participate in Healthcare Conference in March 2019
07/03/2019
PLAINSBORO, N.J., March 07, 2019 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will present at the following healthcare conference in March: [...]
Ovid Therapeutics Reports Fourth Quarter and Full Year 2018 Financial Results
07/03/2019
NEW YORK, March 07, 2019 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (NASDAQ: OVID), a biopharmaceutical company committed to developing medicines that transform the lives of people with rare neurological disorders, [...]
Geron Corporation Reports Fourth Quarter and Full Year 2018 Financial Results and Recent Events
07/03/2019
Conference Call Scheduled for 4:30 p.m. ET today MENLO PARK, Calif., March 07, 2019 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN) today reported financial results for the fourth quarter and full year ended [...]
RTI Surgical® Shareholders Approve Paradigm Spine Acquisition
07/03/2019
ALACHUA, Fla., March 07, 2019 (GLOBE NEWSWIRE) -- RTI Surgical, Inc. (Nasdaq: RTIX), a global surgical implant company, today announced its shareholders have voted to approve completion of the company’s previously [...]
The Joint Corp. Reports Fourth Quarter and Full Year 2018 Financial Results
07/03/2019
- Increases Annual System-Wide Gross Sales 30%, Compared to 2017 - - Achieves Positive Annual Net Income for the First Time of $253,000 - - Sells 99 Franchise Licenses in 2018, Up from 37 in 2017 - SCOTTSDALE, Ariz., [...]
SI-BONE, Inc. Reports Fourth Quarter and Full Year 2018 Financial Results
07/03/2019
Provides Full Year 2019 Financial Outlook SANTA CLARA, Calif., March 07, 2019 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq:SIBN), a medical device company that pioneered the minimally invasive surgical treatment of the [...]
MRI Interventions Announces Agreement with Siemens Healthineers For Interfacing with the Portfolio of Magnetom MRI Scanners
07/03/2019
Agreement Enables the Development of More Efficient Clinical Workflows, Advanced Functionality and Shorter Surgical Procedure Times In the MRI Suite IRVINE, Calif., March 07, 2019 (GLOBE NEWSWIRE) -- MRI Interventions, [...]
Alphatec Spine Reports Fourth Quarter and Full Year 2018 Financial Results
07/03/2019
Secures Additional $30M Financing Commitment from Squadron Capital CARLSBAD, Calif., March 07, 2019 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (“ATEC” or the “Company”) (Nasdaq: ATEC), today announced financial results [...]
Harpoon Therapeutics to Report Fourth Quarter and Full Year 2018 Financial Results
07/03/2019
Webcast and Conference Call to be Held at 4:30 p.m. ET on March 14, 2019 SOUTH SAN FRANCISCO, Calif., March 07, 2019 (GLOBE NEWSWIRE) -- Harpoon Therapeutics, Inc. (NASDAQ: HARP), a clinical-stage immunotherapy company [...]
Aeglea BioTherapeutics Reports Fourth Quarter and Full Year 2018 Financial Results and Corporate Highlights
07/03/2019
On Track to Dose First Patient in Pivotal Phase 3 Trial of Pegzilarginase for ARG1-D in Q2 of 2019 Initiated IND-Enabling Studies for New Pipeline Programs Progress with Pegzilarginase Cancer Indication-Phase 2 [...]
Aravive Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Recent Corporate Updates
07/03/2019
HOUSTON, March 07, 2019 (GLOBE NEWSWIRE) -- Aravive, Inc. (Nasdaq: ARAV), a clinical-stage biopharmaceutical company focused on developing innovative therapies that target important survival pathways for cancer, [...]
Profound Medical Announces Fourth Quarter and Full Year 2018 Financial Results
07/03/2019
TORONTO, March 07, 2019 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSX:PRN; OTCQX:PRFMF) (“Profound” or the “Company”), the only company to provide a therapeutics platform that provides the precision of real-time [...]
Chembio Diagnostics Awarded UNICEF Contract to Supply Point-of-Care Zika/Chikungunya/Dengue Tests and Micro Readers
07/03/2019
MEDFORD, N.Y., March 07, 2019 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leader in point-of-care diagnostic tests for infectious diseases, today announced that it will be awarded a conditional Long [...]
La Jolla Pharmaceutical Company to Present at the 39th Annual Cowen Healthcare Conference
07/03/2019
SAN DIEGO, March 07, 2019 (GLOBE NEWSWIRE) -- La Jolla Pharmaceutical Company (Nasdaq: LJPC), a leader in the discovery, development and commercialization of innovative therapies intended to significantly improve [...]
ChromaDex Corporation Reports 2018 Financial Results
07/03/2019
- Full Year 2018 Net Revenues Increased by 49% to $31.6 Million and Fourth Quarter 2018 Net Revenues Increased by 20% to $9.1 Million - Fourth Quarter 2018 Highlights vs. Fourth Quarter 2017 Entered into a global [...]

Pages